SavedAdd your journal

Journals / Türk Geriatri Dergisi / 2011 / Cilt: 14 - Sayı: 2

Is age a contraindication for laporoscopic anti-reflux surgery in elderly

Yaşlı hastalarda laparoskopik anti-reflü cerrahi uygulaması için yaş bir kontrendikasyon mudur?

Mehmet Ali YERDEL
Toygar TODEMİR
Koray TEKİN
Pages
95–100
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Age should not be a contraindication to LARS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study is to assess the safety of laparoscopic anti-reflux surgery (LARS) in the elderly.
📊
Key Findings & Data:Materials and Method: A total of 1000 patients underwent a LARS procedure between May 2004 and November 2009.
💡
Conclusion & Impact:Age should not be a contraindication to LARS.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study is to assess the safety of laparoscopic anti-reflux surgery (LARS) in the elderly. Materials and Method: A total of 1000 patients underwent a LARS procedure between May 2004 and November 2009. Patients over 60 years were defined as group A (A) and under 60 years were defined as group B (B). All data, including demographics, operative details, operative/ postoperative complications and outcomes were recorded in a prospective database. Results: There were 48 paients in A and 952 patients in B. The mean age of A and B was 64, and 39 respectively.(p0.05) Hiatal hernia was more common in A(81%) opposed to B (77%)(p=0.001).Toupet was performed more frequently in A (52%) opposed to B (31%) (p=0.002).There was no mortality and conversion. Esophageal perforation, jejunal perforation and pulmonary emboli were the major complications and were seen only in B(p>0.05). All other minor complications and postoperative dysphagia, bloating and reflux recurrence were similiar among the groups.(p>0.05) Conclusion: LARS is a safe procedure in patients over 60 years old. Age should not be a contraindication to LARS.

Özet

Giriş: Bu çalışmada amaç, laparoskopik anti-reşü cerrahi (LARC) uygulamasının, yaşlı hasta grubundaki güvenirliliğini değerlendirmektir. Gereç ve Yöntem: Mayıs 2004 ile Kasım 2009 arasında 1000 hastaya LARC uygulandı. Altmı ş yaş üzeri olan hastalar A grubunu (A), 60 yaş altı olan hastalar ise B grubunu (B) oluşturdu. Preoperatif klinik, operasyon detayları ve perioperatif bulgular, prospektif veri tabanında analiz edildi. Bulgular: A’da 48, B’de 952 hasta mevcuttu. Yaş ortalaması A için 64, B için 39 idi. (p0.05). Hiatal herni varlığı A’da %81, B’de %77 idi (p=0.001). Toupet A’da (%52) B’ye (%31) göre daha fazla uygulanan prosedürdü (p=0.002). Her iki grupta da mortalite ve açığa dönme olmadı. Postoperatif tüm minör komplikasyonlar gruplar arasında benzerdi (p>0.05). Majör komplikasyon olarak, yalnız B’de, üç hastada ösefagus perforasyonu, ince barsak perforasyonu ve pulmoner emboli görüldü (p>0.05). Postoperatif gas-bloat, yutma güçlüğü ve nüks yüzdeleri gruplar arası benzerdi (p>0.05). Sonuç: LARC 60 yaş üzeri hastalarda da güvenli bir şekilde uygulanabilir. Yaş LARC için bir kontrendikasyon olmamalıdır.

🔖

Cite This Article

YERDEL, M. A., TODEMİR, T., TEKİN, K. (2022). Is age a contraindication for laporoscopic anti-reflux surgery in elderly. Türk Geriatri Dergisi, Cilt: 14 - Sayı: 2, 95–100. https://ajindex.com/articles/624043

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Evers BM, Townsendcm Jr, Thompson JC. Organ physiology of aging. Surg Clin North Am 1994;74:23-39
  2. Allen R, Rappaport W, Hixson L, Sampliner R, Case T, Fennerty MB. Referral patterns and the results of antireflux operations in patients more than sixty years of age. Surg Gynecol Obstet 1991;173:359-62
  3. Raiha IJ, Impivaara O, Seppala M, Sourander LB. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc 1992;40:1209-11
  4. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710–7
  5. Richards WO, Houston HL, Torquati A, Khaitan L, Holzman MD, Sharp KW. Paradigm shift in the management of gastroesophageal reflux disease. Ann Surg 2003;237:638-47
  6. Zhu H, Pace F, Sangaletti O, Bianchi Porro G. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993;28:235-8
  7. Holt PR. Gastrointestinal diseases in the elderly. Curr Opin Clin Nutr Metab Care. 2003;6:41-8
  8. Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991;101:977–90
  9. Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol 1995;90:1053–7
  10. Monnier P, Ollyo JP, Fontolliet C. Epidemiology and natural history of reflux esophagitis. Semin Laparosc Surg 1995;2:2–9
  11. Rantanen TK, Salo JA. Gastroesophageal reflux disease as a cause of death: analysis of fatal cases under conservative treatment. Scand J Gastroenterol 1999;34:229-33
  12. Cote GA, Howden CW. Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep 2008;10(3):208-14
  13. Garnett WR, Garabedian-Ruffalo SM. Identification, diagnosis, and treatment of acid-related diseases in the elderly: implications for long-term care. Pharmacotherapy 1997;17:938-58
  14. Terry M, Smith CD, Branum GD, Galloway K, Waring JP, Hunter JG. Outcomes of laparoscopic Nissen fundoplication for gastroesophageal reflux disease and paraesophageal hernia. Surg Endosc 2001;15:691–9
  15. Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994;220:472–83
  16. Arnavd JP, Pessaux P, Ghavami B, Flamont JB, Trebuchet G, Meyer C, e